Logo-bi
BioImpacts. 2021;11(3): 219-226. doi: 10.34172/bi.2021.31
PMID: 34336610        PMCID: PMC8314037

Original Research

Therapeutic effects of bone marrow mesenchymal stem cells via modulation of TLR2 and TLR4 on renal ischemia-reperfusion injury in male Sprague-Dawley rats

Zeinab Karimi 1 ORCID, Sahar Janfeshan 1, Elias Kargar Abarghouei 2, Seyedeh-Sara Hashemi 3 * ORCID

Cited by CrossRef: 4


1- Guan C, Li C, Shen X, Yang C, Liu Z, Zhang N, Xu L, Zhao L, Zhou B, Man X, Luo C, Luan H, Che L, Wang Y, Xu Y. Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway. Eur J Med Res. 2023;28(1) [Crossref]
2- Abdolmohammadi K, Mahmoudi T, Alimohammadi M, Tahmasebi S, Zavvar M, Hashemi S. Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation. Life Sciences. 2023;312:121206 [Crossref]
3- Karimi Z, Ghahramani P, Masjedi F, Yavari V. Klotho plays a crucial role in the renal-protective effect of allopurinol on renal ischemia-reperfusion injury. The American Journal of the Medical Sciences. 2024; [Crossref]
4- Luo C, Luo F, Che L, Zhang H, Zhao L, Zhang W, Man X, Bu Q, Luan H, Zhou B, Zhou H, Xu Y. Mesenchymal stem cells protect against sepsis-associated acute kidney injury by inducing Gal-9/Tim-3 to remodel immune homeostasis. Renal Failure. 2023;45(1) [Crossref]


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge